Evidence map›Paper›PMID 34862317›Full record

ArticleNeurology2022

Disorders of Consciousness Associated With COVID-19: A Prospective Multimodal Study of Recovery and Brain Connectivity.

David Fischer, Samuel B Snider, Megan E Barra, William R Sanders, Otto Rapalino, Pamela Schaefer, Andrea S Foulkes, Yelena G Bodien, Brian L Edlow

Registry-linked trialAbstract read
In one paragraph

Article in Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04476589 (Prognostication of Recovery in Early Disorders of Consciousness After COVID-19), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04476589 completednot on this map

Prognostication of Recovery in Early Disorders of Consciousness After COVID-19

TypeobservationalSponsorMassachusetts General HospitalRan2020 to 2022Enrolled12ConditionsCovid19, Coma, Consciousness DisorderArmsFunctional MRI
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms.European journal of nuclear medicine and molecular imaging · 2025
    Article
  9. Review
  10. Article
  11. Altered brain function and structure pre- and post- COVID-19 infection: a longitudinal study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David FischerFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown. d.b.fisch@gmail.com.ORCID 0000-0001-8181-0643
Samuel B SniderFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.
Megan E BarraFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.
William R SandersFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.
Otto RapalinoFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.ORCID 0000-0002-5038-4183
Pamela SchaeferFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.
Andrea S FoulkesFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.
Yelena G BodienFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.
Brian L EdlowFrom the Department of Neurology, (D.F., M.E.B., W.R.S., Y.G.B., B.L.E.), Center for Neurotechnology and Neurorecovery, Department of Pharmacy (M.E.B.), Department of Radiology (O.R., P.S.), and Department of Medicine (A.S.F.), Massachusetts General Hospital and Harvard Medical School; Division of Neurocritical Care (D.F., S.B.S.), Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston; Department of Physical Medicine and Rehabilitation (Y.G.B.), Spaulding Rehabilitation Hospital; and Athinoula A. Martinos Center for Biomedical Imaging (B.L.E.), Massachusetts General Hospital and Harvard Medical School, Charlestown.ORCID 0000-0001-7235-8456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesIn patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (DoC) have emerged as a serious complication. The prognosis and pathophysiology of COVID-DoC remain unclear, complicating decisions about continuing life-sustaining treatment. We describe the natural history of COVID-DoC and investigate its associated brain connectivity profile.

methodsIn a prospective longitudinal study, we screened consecutive patients with COVID-19 at our institution. We enrolled critically ill adult patients with a DoC unexplained by sedation or structural brain injury and who were planned to undergo a brain MRI. We performed resting-state fMRI and diffusion MRI to evaluate functional and structural connectivity compared to healthy controls and patients with DoC resulting from severe traumatic brain injury (TBI). We assessed the recovery of consciousness (command following) and functional outcomes (Glasgow Outcome Scale Extended [GOSE] and the Disability Rating Scale [DRS]) at hospital discharge and 3 and 6 months after discharge. We also explored whether clinical variables were associated with recovery from COVID-DoC.

resultsAfter screening 1,105 patients with COVID-19, we enrolled 12 with COVID-DoC. The median age was 63.5 years (interquartile range 55-76.3 years). After the exclusion of 1 patient who died shortly after enrollment, all of the remaining 11 patients recovered consciousness 0 to 25 days (median 7 [5-14.5] days) after the cessation of continuous IV sedation. At discharge, all surviving patients remained dependent: median GOSE score 3 (1-3) and median DRS score 23 (16-30). Ultimately, however, except for 2 patients with severe polyneuropathy, all returned home with normal cognition and minimal disability: at 3 months, median GOSE score 3 (3-3) and median DRS score 7 (5-13); at 6 months, median GOSE score 4 (4-5), median DRS score 3 (3-5). Ten patients with COVID-DoC underwent advanced neuroimaging; functional and structural brain connectivity in those with COVID-DoC was diminished compared to healthy controls, and structural connectivity was comparable to that in patients with severe TBI. DISCUSSION: Patients who survived invariably recovered consciousness after COVID-DoC. Although disability was common after hospitalization, functional status improved over the ensuing months. While future research is necessary, these prospective findings inform the prognosis and pathophysiology of COVID-DoC. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov identifier: NCT04476589.

Indexed as

Consciousness DisordersCOVID-19AgedBrainHumansLongitudinal StudiesMagnetic Resonance ImagingMiddle AgedProspective StudiesRecovery of Function

Identifiers

PMID34862317
PMCPMC8792809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.